Cabazitaxel

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Cabazitaxel
CAS No.:183133-96-2
Standard:In-house Standards
Price(USD):Negotiable
Company:Quanzhou Fortune Biopharma Co.,Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Quanzhou

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: L/C

    Cabazitaxel Jevtana is a microtubule inhibitor that is indicated in combination with Prednisone or Prednisolone for the treatment of hormone refractory metastatic prostate cancer in patients who have been treated with Docetaxel containing docetaxel. Carbataxel Jevtana can inhibit cancer cell growth and even cause cancer cell death. Clinical trials have shown that it can also shrink tumors and slow the growth or spread of tumors to relieve symptoms of prostate cancer and improve patients' quality of life.

Send your message to this supplier
  • From:
  • To:
    Quanzhou Fortune Biopharma Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service